The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|11|2|242-246

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.2, 2011-01, pp. : 242-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 8, 2012-10 ,pp. : 891-901

Bentham Science Publishers

Access to resources Recommend Favorite

The Ubiquitin-Proteasome Pathway an Emerging Anticancer Strategy for Therapeutics: A Patent Analysis

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 2, 2015-05 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the ubiquitin–proteasome pathway in breast cancer therapy

By Dees E Claire   Orlowski Robert Z  

Future Oncology, Vol. 2, Iss. 1, 2006-02 ,pp. : 121-135

Future Medicine

Access to resources Recommend Favorite

Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 3, 2007-05 ,pp. : 359-365

Bentham Science Publishers

Access to resources Recommend Favorite

Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway

By                      

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 1204-1212

Spandidos Publications

Access to resources Recommend Favorite